Patents by Inventor Stéphanie BOUDON

Stéphanie BOUDON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
    Patent number: 10550097
    Abstract: The present invention relates to novel selective 11-beta-hydroxysteroid dehydrogenase type 1 (11?-HSD1) inhibitors and the use thereof to prevent age-induced skin structure and function defects.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: February 4, 2020
    Assignee: DSM IP ASSETS B.V.
    Inventors: Stéphanie Boudon, Piero Geotti-Bianchini, Marc Heidl, Eileen Jackson, Alexander Schlifke-Poschalko
  • (R)-N-(adamantyl-2-yl)pyrrolidine-2-carboxamide derivatives for cosmetic use
    Patent number: 10470991
    Abstract: The present invention relates to novel selective 11-beta-hydroxysteroid dehydrogenase type 1 (11?-HSD1) inhibitors and the use thereof to prevent age-induced skin structure and function defects.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: November 12, 2019
    Assignee: DSM IP ASSETS B.V.
    Inventors: Stephanie Boudon, Marc Heidl, Eileen Jackson
  • Phosphinic peptide derivatives for use as MMP-12 inhibitors
    Patent number: 10179797
    Abstract: This invention relates to compounds that are selective inhibitors of Matrix Metalloprotease-12 (MMP-12), to cosmetic and pharmaceutical compositions containing them, and to their use in the prevention and/or treatment of ailments associated with MMP-12. Formula (I).
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: January 15, 2019
    Assignee: DSM IP ASSETS B.V.
    Inventors: Stéphanie Boudon, Eileen Jackson, Rolf Schuetz, Jürgen Herbert Vollhardt, Peter Wikstroem, Eliane Ursula Wandeler
  • (R)-N-(ADAMANTYL-2-YL)PYRROLIDINE-2-CARBOXAMIDE DERIVATIVES FOR COSMETIC USE
    Publication number: 20180344604
    Abstract: The present invention relates to novel selective 11-beta-hydroxysteroid dehydrogenase type 1 (11ß-HSD1) inhibitors and the use thereof to prevent age-induced skin structure and function defects.
    Type: Application
    Filed: December 9, 2016
    Publication date: December 6, 2018
    Inventors: Stephanie BOUDON, Marc HEIDL, Eileen JACKSON
  • PHOSPHINIC PEPTIDE DERIVATIVES FOR USE AS MMP-12 INHIBITORS
    Publication number: 20180319829
    Abstract: This invention relates to compounds that are selective inhibitors of Matrix Metalloprotease-12 (MMP-12), to cosmetic and pharmaceutical compositions containing them, and to their use in the prevention and/or treatment of ailments associated with MMP-12. Formula (I).
    Type: Application
    Filed: November 23, 2016
    Publication date: November 8, 2018
    Inventors: Stéphanie BOUDON, Eileen JACKSON, Rolf SCHUETZ, Jürgen Herbert VOLLHARDT, Peter WIKSTROEM, Eliane Ursula WANDELER
  • NOVEL SELECTIVE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1
    Publication number: 20180208576
    Abstract: The present invention relates to novel selective 11-beta-hydroxysteroid dehydrogenase type 1 (11?-HSD1) inhibitors and the use thereof to prevent age-induced skin structure and function defects.
    Type: Application
    Filed: July 7, 2016
    Publication date: July 26, 2018
    Inventors: Stéphanie BOUDON, Piero GEOTTI-BIANCHINI, Marc HEIDL, Eileen JACKSON, Alexander SCHLIFKE-POSCHALKO